FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3883411000001108: Nateglinide 180mg tablets 84 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21749501000001113 Nateglinide 180mg tablets 84 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21749601000001112 Nateglinide 180mg tablets 84 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nateglinide 180mg tablets 84 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Is pack of Product containing precisely nateglinide 180 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Has active ingredient Nateglinide false Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Has VMP Product containing precisely nateglinide 180 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Has specific active ingredient Nateglinide true Inferred relationship Existential restriction modifier
Nateglinide 180mg tablets 84 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 7 x 12 tablets Is a True Nateglinide 180mg tablets 84 tablet Inferred relationship Existential restriction modifier
Starlix 180mg tablets (PI) (Waymade Ltd) 84 tablet 7 x 12 tablets Is a True Nateglinide 180mg tablets 84 tablet Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Sigma Pharmaceuticals Plc) 84 tablet Is a True Nateglinide 180mg tablets 84 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start